Rocha Lima CM, Rizvi NA, Zhang C, Herndon JE 2nd, Crawford J, Govindan R, King GW, Green MR. Cancer Leukemia Group B. Random Phase II trial of Gemcitabine and docetaxel or Irinotecan and Gemcitabine in advanced or metastatic NSCLC. 2004; 15(3):410-8.